Clinical Categories

Neuroimmunology

Latest News & More see all

How do multiple sclerosis drugs affect pregnancy?

Dec. 18, 2024

News Releases
Cutting early life exposure to parental smoking may lower multiple sclerosis risk in genetically prone

Dec. 11, 2024

News Releases
How long does it take to recover from “brain on fire” disorder?

Nov. 21, 2024

News Releases
Navigating the financial and ethical challenges of high-cost biologicals in neurology

Oct. 14, 2024

Blog
Do people with multiple sclerosis have an increased risk of cancer?

Oct. 11, 2024

News Releases
Study finds certain multiple sclerosis therapies may not slow disability progression

Sep. 27, 2024

News Releases
Key biomarkers identified for predicting disability progression in multiple sclerosis

Sep. 23, 2024

News Releases
Scientists publish protocol for combining aerobic exercise and cognitive rehabilitation in multiple sclerosis

Sep. 03, 2024

News Releases

Subscribe to MedLinkNeurology

Comprehensive neurology coverage with unmatched breadth. Thousands of images, videos, and illustrations. Hundreds of patient handouts. CME credits. Unlock all these benefits and more. Start your membership today.

Discounts are available for Students, Residents, Fellows, Retirees, APPs, and physicians practicing in developing nations. See Plans & Pricing for more information

Earn CME Credits for reading MedLink Neurology articles.
Each article is meticulously reviewed for accuracy by our esteemed Editorial Board.
Over 3,000 illustrations, including videos of neurologic disorders.
A world of neurology information contained in over 1,250 articles.

Neuroimmunology

Latest Articles see all

Autoantibodies: mechanism and testing

Multiple sclerosis: treatment of its symptoms

Anti-GQ1b antibody syndrome

Paraneoplastic syndromes

Anti-IgLON5 disease

Balo concentric sclerosis

Anti-LGI1 encephalitis

Progressive encephalomyelitis with rigidity and myoclonus and glycine receptor antibodies

Giant cell arteritis

Chronic inflammatory demyelinating polyradiculoneuropathy

Autoimmune autonomic neuropathy

HTLV-1 associated myelopathy

Myositis and cancer

Paraneoplastic retinopathy

Radiologically isolated syndrome

Latest News & More see all

How do multiple sclerosis drugs affect pregnancy?

Cutting early life exposure to parental smoking may lower multiple sclerosis risk in genetically prone

How long does it take to recover from “brain on fire” disorder?

Navigating the financial and ethical challenges of high-cost biologicals in neurology

Do people with multiple sclerosis have an increased risk of cancer?

Study finds certain multiple sclerosis therapies may not slow disability progression

Key biomarkers identified for predicting disability progression in multiple sclerosis

Scientists publish protocol for combining aerobic exercise and cognitive rehabilitation in multiple sclerosis

Patient Handouts see all

Vasculitis syndromes of the central and peripheral nervous systems

Transverse myelitis

Myasthenia gravis

Multiple sclerosis

Lupus

Behcet disease

Chronic inflammatory demyelinating polyneuropathy

Acute disseminated encephalomyelitis

External Resources see all

FDA approves Kevzara® (sarilumab) for polymyalgia rheumatica

FDA approves ZILBRYSQ® (zilucoplan) for adults with generalized myasthenia gravis

FDA approves VYVGART Hytrulo injection for subcutaneous use in myasthenia gravis

FDA approves RYSTIGGO®(rozanolixizumab-noli) for adults with generalized myasthenia gravis

FDA approves Tyruko® (natalizumab-sztn) for relapsing forms of multiple sclerosis

FDA approves HYQVIA® as maintenance therapy in adults with CIDP

The Autoimmune Registry

NIH: IgG4-related disease

Media see all

Subscribe to MedLinkNeurology

Neuroimmunology Contributors